ABSTRACT
Completing the building of a moderately prosperous society in all respects involves various aspects, but it is an imperative task to strengthen areas of weakness.China is a developing country with relatively insufficient medical resources.Yet without health for all, there can be no well-off society for all.The incidence of cancer has been among the top three, playing an important role in the work of national health.Among them, the department of oncology of the First Affiliated Hospital of Anhui University of Technology takes care of cancer patients by holding public lectures——famous doctors' lecture hall, establishing family poverty alleviation wards, establishing " cloud medical treatment" ——WeChat group and distributing brochures during tumor publicity week. All the methods are creative, evaluable and sustainable.It will be further improved in the future to provide more help for cancer patients.
ABSTRACT
Objective To study the curative effect and characteristics of all -transretinoic acid (ATRA) and arsenic acid (As2 O3 )combination chemotherapy for acute promyelocytic leukemia (APL).Methods ATRA (30 -60mg/d),As2 O3 (0.1%As2 O3 d1 -28),chemotherapy(anthracycline -based chemotherapy regimens and homoharringtonine -based chemotherapy regimens or high -doses of cytosine arabinoside and small -doses of metho-trexate)were used alternately 4 -5 cycles.Results 12 cases had complete response(CR),CR rate was 100%,first cases and relapse cases all got CR,the median time needed 30 days to get CR.Follow -up deadline,all cases 10 year disease -free survival (DFS )rate was 100%,all reexamination minimal residual disease (MRD)was negative. Conclusion Using this method to treat adult APL,the CR rate is high,has less adverse reaction,and did not produce resistance phenomenon.It can be used for APL consolidation and maintenance therapy.This is one of the ways that can be recommended in the treatment.
ABSTRACT
Objective To study the clinical efficacy of thermotherapy combined chemotherapy in the treatment of the advanced non-small cell lung carcinoma with neuroendocrine differentiation (NSCLC-NED).Methods The clinical data of 16 patients with NSCLC-NED were retrospectively reviewed.To analyzed the efficacy and survival of these patients.All patients were treated by thermotherapy with the combined chemotherapy regiment of platinum agents.Results There were 7 partial responses and 4 stable disease,The overall response rate (RR) was 43.8％.The one year survival rate was 37.5％ (6/16).The improvement rate of quality of life was 62.5％ (10/16).Conclusion Neuroendocrine differentiation is an important indicator of biological behavior of NSCLC.Thermochemotherapy is an active regimen in the advanced NSCLC-NED with an acceptabe toxicity.